Clinical trial
Safety and Efficacy Study of Etanercept (Enbrel) on the Response Rate of…
NCT00091741 · Georgetown University, Other · Completed
Key facts
| NCT number | NCT00091741 |
|---|---|
| Title | Safety and Efficacy Study of Etanercept (Enbrel) on the Response Rate of HIV-infected Subjects |
| Official title | A Phase I Pilot Study to Evaluate Safety and Efficacy of Etanercept (Enbrel) on the Response Rate of HIV-infected Subjects Who Are in Virologic Failure and Who Have Failed to Respond to Standard Antiretroviral Therapy |
| Lead sponsor | Georgetown University, Other |
| Collaborators | Advanced Biotherapy, Inc. Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | HIV Infection |
| Intervention type | Drug |
| Interventions | Etanercept (Enbrel) |
| Enrollment | 10 |
| Completion | Oct 1, 2004 |
| First posted | Sep 20, 2004 |
| Last update posted | Jul 22, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: